HOME | SITE MAP | LEGAL

 

U.S. House of Representatives, Committee on Energy and Commerce
"SARS: Assessment, Outlook, and Lessons Learned" (May 7, 2003)

On Wednesday, May 7, 2003, Robert J. Capetola, Ph.D, President and CEO of Discovery, appeared in Washington, D.C. to testify before the House Committee on Energy and Commerce Subcommittee on Oversight and Investigations regarding the possible application of the Company’s Surfactant Replacement Therapy programs, aimed at maintaining or restoring lung function in hospitalized patients, to address Severe Acute Respiratory Syndrome (SARS). The hearing, titled “SARS: Assessment, Outlook, and Lessons Learned” covered government response, public health issues and commercial drug development initiatives targeting the SARS crisis. 

 Dr. Capetola's prepared testimony on Surfactant Replacement Therapy for SARS

 Connect to the archive of this hearing webcast


 

Dr. Capetola with Congressman James Greenwood who represents the 8th Congressional District of Pennsylvania and is Chairman of the Energy and Commerce Committee's Subcommittee on Oversight and Investigations on Wednesday, May 7, 2003 at the SARS Hearing in Washington, D.C.

Click on the picture to view it larger


 

Anthony S. Fauci, M.D., Director of National Institute of Allergy and Infectious Disease, National Institute of Health, Bethesda, Maryland with Dr. Capetola on Wednesday, May 7, 2003 at the SARS Hearing in Washington, D.C.

Click on the picture to view it larger


 

Pete Krauss, Chief of Staff to Congressman James Greenwood with Dr. Capetola on Wednesday, May 7, 2003 at the SARS Hearing in Washington, D.C.

Click on the picture to view it larger

Discovery Laboratories, Inc. occasionally receives attention from the media in the form of television and news coverage and newspaper and magazine articles. This information is being provided to you on a information basis only. The information contained in these presentations was current as of the dates listed and reflected management’s views as of those dates. The presentations contain certain forward-looking information that involve inherent risks and uncertainties, known and unknown, that could cause outcomes and results to differ materially from those expressed or implied by such statements. We undertake no obligation to publicly update any information in the presentations, which speak as of their respective dates.

This website may link you to other websites that are not owned or controlled by Discovery. These links are provided for your convenience only. These sites are maintained by entities over which Discovery exercises no control. Accordingly, Discovery expressly disclaims any responsibility for the content, the accuracy of the information and/or quality of products or services provided by or advertised on these third-party sites. If you choose to hyperlink to another website, you do so at your own risk.